Cargando…
Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead
Autores principales: | Alexopoulos, Anastasia-Stefania, Crowley, Matthew J., Kahkoska, Anna R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234739/ https://www.ncbi.nlm.nih.gov/pubmed/37220268 http://dx.doi.org/10.2337/dci23-0017 |
Ejemplares similares
-
Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2021) -
A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019
por: Evans, Marc, et al.
Publicado: (2019) -
Diabetes, COVID-19 and Mucormycosis: Unanswered Questions!
por: Rastogi, Ashu, et al.
Publicado: (2021) -
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Private medical autopsies - The road ahead!
por: Aggrawal, A
Publicado: (2023)